INS and diabetes mellitus: To assess whether O304 could enhance glucose effectiveness and thus ameliorate diabetes in an insulin deficient context, diabetes was induced by ablating β-cell function through streptozotocin (STZ) injections in 9–11 weeks (w) old male C57BL/6J × CBA F1 mice.